The Gates Foundation will add another $70 million of funding for vaccines and treatments against coronavirus disease 2019 (COVID-19); nursing homes see rising COVID-19 cases; finding health coverage for workers laid off due to the pandemic.
As reported by Reuters, the Gates Foundation announced today it will be adding another $70 million of funding to global efforts to develop and distribute vaccines and treatments against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). Of the money pledged, $50 million will go to the COVAX Advance Market Commitment (AMC) led by the Gavi vaccine alliance, with the remaining $20 million given to the Coalition for Epidemic Preparedness Innovations. GAVI has said that it plans to secure 2 billion doses of COVID-19 vaccines by the end of 2021, of which almost 1 billion doses will be available to the 92 poorest countries through the AMC.
After 7 weeks of steady decline, COVID-19 cases in nursing homes rose by more than 40% from mid-September to October 25, with nursing home operators saying it’s nearly impossible to keep the virus contained while cases spike across communities nationwide. POLITICO reports that during each period of heightened community spread, cases have consistently increased in nursing homes. In Wisconsin, 112 long-term care facilities reported new COVID-19 outbreaks in the last week, a stark figure nearly double the prior week’s increase.
An article published by Kaiser Health News spotlighted workers who lost their job and health insurance due to the COVID-19 pandemic. While there is no official tally, studies indicate that at least 10 million workers have lost their health insurance, with almost two-thirds having subsequently found alternative coverage through a new job, Medicaid, or the marketplaces made available by the Affordable Care Act (ACA). In California, almost 300,000 residents have enrolled in the state’s ACA marketplaces, while in New York, state officials and private groups have helped those unemployed with enrolling in state-supported programs.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More